Virax Biolabs Group Ltd

NASDAQ: VRAX
Share price (5/13/24): $0.79
Market cap (5/13/24): $11.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/23 FY 2023

ended 03/31/22 FY 2022

Late filing notification for annual report of foreign issuer

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement

Prospectus supplement

Shelf registration

Exempt offering of securities

Ownership Filter

Armistice Capital, LLC

News Filter

Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

To Participate at ESCMID Global 2024

Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Material disclosure

Unaudited Condensed Consolidated Interim Financial Statements as of September 30, 2023

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC